Abstract Neuroleptic Malignant Syndrome (NMS) is an idiosyncratic and potentially life-
threatening reaction to neuroleptic drugs. Lithium is a first-line mood stabilizer used in the …

We report a case of neuroleptic malignant syndrome (NMS). Lithium toxicity might have
predisposed to the development of the syndrome in our patient. The patient had …

Neuroleptic malignant syndrome (NMS) is a rare but life‐threatening complication of
antipsychotic therapy. The classic features of NMS include muscular rigidity, altered mental …

Introduction. We present the case of a patient who developed lithium toxicity with normal
therapeutic levels, as a result of pharmacokinetic interaction with Valsartan, and probable …

Discussion The diagnosis of NMS was established based on Levenson's criteria, 3 after
carefully ruling out other pertinent differential diagnoses of sepsis, lithium intoxication …

A 39-year-old female with a 20-year history of bipolar disorder was admitted due to a
recurrence of a manic episode with psychotic symptoms. She was treated with standard …

To the Editor: Neuroleptic malignant syndrome (NMS), an idiosyncratic and potentially life-
threatening complication of psychotropic medications, is typically manifested with …

Whether there is an increased risk of occurrence of neuroleptic malignant syndrome (NMS)
on combined treatment with lithium and neuroleptic is a controversial issue. Patients seen in …

A 45‐year‐old man was admitted to our hospital after taking an intentional overdose of 90
sustained‐released lithium tablets (450 mg each). The patient was stabilized with three …

This case proposes that lithiuminduced NDI may increase the vulnerability for NMS. Patients
with lithium-induced NDI are at an increased risk of dehydration, especially if adequate …